Mutations profile in Chinese patients with hypertrophic cardiomyopathy
- 1 January 2005
- journal article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 351 (1-2), 209-216
- https://doi.org/10.1016/j.cccn.2004.09.016
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Mutations of the myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosisHeart, 2003
- Hypertrophic CardiomyopathyCirculation, 2003
- Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic CardiomyopathyCirculation, 2002
- The Genetic Basis for CardiomyopathyCell, 2001
- Malignant Hypertrophic Cardiomyopathy Caused by the Arg723Gly Mutation in β -Myosin Heavy Chain GeneJournal of Molecular and Cellular Cardiology, 2000
- The Origins of Hypertrophic Cardiomyopathy–Causing Mutations in Two South African Subpopulations: A Unique Profile of Both Independent and Founder EventsAmerican Journal of Human Genetics, 1999
- AT 1 Receptor A/C 1166 Polymorphism Contributes to Cardiac Hypertrophy in Subjects With Hypertrophic CardiomyopathyHypertension, 1998
- Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.JCI Insight, 1994
- Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene.JCI Insight, 1993
- A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutationCell, 1990